A Canadian Discovery Moves from the Lab to Clinical Trials

A new potential treatment for diabetic macular edema and agerelated macular degeneration has been discovered by Canadian scientist Dr. Przemyslaw (Mike) Sapieha (Université de Montréal).

The primary treatment for these diseases is anti-VEGF injections which stop the growth of blood vessels. One of the problems with this type of treatment is that all blood vessel growth is stopped; both abnormal blood vessels and sometimes healthy blood vessels which are needed to keep the eye healthy and protect vision.

In a new study published in Cell Metabolism, Dr. Sapieha’s team identified a way to distinguish between healthy and diseased blood vessels. They identified a molecule, BCL-xL, that is higher in abnormal blood vessels compared to healthy vessels. Dr. Sapieha then teamed up UNITY Biotechnology, who have developed drugs that block BCL-xL function. One of these drugs slowed the growth of abnormal vessels in a mouse model of retinal degeneration while allowing healthy blood vessels to survive.

This class of drugs is now being tested in a Phase I human clinical trial to determine safety in individuals with diabetic macular edema or wet age-related macular degeneration.

Featured Posts

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read More

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read More

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read More

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read More

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Learn More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

OGS Encourages Donations to “Light Up Their Eyes This Holiday Season”

To raise awareness of its global impact and encourage fundraising through the end of the year, Optometry Giving Sight (OGS) has kicked off its “Light Up Their Eyes This Holiday Season” campaign.

Read more

Glamourama Vol.2: A Love Story

Etnia Barcelona presents eight new acetate models of prescription glasses and five new sunglasses for its Vintage collection.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Read more